Premium
Medication‐related osteonecrosis of the maxilla: Prognosis of oral surgery combined with endoscopic sinus surgery
Author(s) -
Park JungHyun,
Alfafara Angenine Marie,
Park Young Long,
Bae JungHo,
Kim SunJong
Publication year - 2021
Publication title -
oral diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.953
H-Index - 87
eISSN - 1601-0825
pISSN - 1354-523X
DOI - 10.1111/odi.13615
Subject(s) - medicine , functional endoscopic sinus surgery , maxillary sinus , sinusitis , concomitant , radiological weapon , surgery , osteonecrosis of the jaw , maxilla , stage (stratigraphy) , dentistry , bisphosphonate , osteoporosis , paleontology , biology
Objectives To evaluate the effect of functional endoscopic sinus surgery (FESS) on the resolution of maxillary medication‐related osteonecrosis of the jaw (MRONJ). Patients and Methods This study included 62 patients diagnosed with MRONJ in the maxillary posterior area with or without maxillary sinusitis (MS). All patients underwent oral surgery. The concomitant MS was evaluated, and if indicated, FESS was performed on the same operation. Follow‐up included clinical and radiological examinations at 4 months postoperation. Results Of the 62 patients, 24 (38.7%) showed no evidence of MS and 38 (61.3%) showed MS. Advanced MRONJ (stage 3), which has bony destruction of the sinus floor and signs of MS according to its definition, was seen in 27 patients (43.5%). In stage 3 MRONJ, patients with combined treatment of oral surgery and FESS compared to those treated with oral surgery alone showed higher percentage of resolution (84.2%, 37.5%, respectively) at 4 months postoperatively, and the results were statistically significant. Conclusion Simultaneous management of MRONJ and sinusitis with combined treatment of oral surgery and FESS for the treatment of maxillary MRONJ can be an effective method, especially for advanced cases, to address its associated lesions.